Search
Search Results
##search.searchResults.foundPlural##
-
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1533PDF: 944HTML: 223 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3174PDF: 1151HTML: 394 -
COST OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN INDIA
2675PDF: 968HTML: 4703 -
FUNGAL INFECTIONS OF THE EAR IN IMMUNOCOMPROMISED HOST: A REVIEW
3583PDF: 1370HTML: 3738Letter to Editor: 187 -
AN OBSERVATIONAL STUDY OF THE EFFECT OF HEMOGLOBINOPATHY, ALPHA THALASSEMIA AND HEMOGLOBIN E ON P. VIVAX PARASITEMIA
2777PDF: 888HTML: 376Distribution of malaria patient cohort along Thailand and borders during 2011-2012: 194 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1773PDF: 1074HTML: 249 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2000PDF: 1138HTML: 627 -
ACUTE LUNG INJURY COMPLICATING BLOOD TRANSFUSION IN POST-PARTUM HEMORRHAGE: INCIDENCE AND RISK FACTORS.
2445PDF: 1228HTML: 3600Acute lung injury complicating blood transfusion in post-partum hemorrhage: incidence and risk factors.: 409 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4089PDF: 1240HTML: 1955Table 1: 197 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1431PDF: 808HTML: 316 -
PREVALENCE OF ALPHA THALASSEMIA IN MICROCYTIC ANEMIA: A TERTIARY CARE EXPERIENCE FROM NORTH INDIA
2420PDF: 1229HTML: 4701table: 205fig 1: 216fig 2: 175 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1002PDF: 539HTML: 7810 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4810PDF: 1788HTML: 2707Untitled: 219 -
Severe autoimmune hemolytic anemia in Covid-19 infection Autoimmune hemolytic anemia in Covid-19
3199PDF: 1580HTML: 259 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3384PDF: 1293HTML: 1890Fig.1: 200Fig. 2: 208 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1378HTML: 435PDF: 822 -
MODULATING EFFECT OF THE ?158 G? (C?T) XMN-1 POLYMORPHISM IN INDIAN SICKLE CELL PATIENTS
1515PDF: 900HTML: 1431Table: 189 -
EXTREMELY OLD PATIENTS HOSPITALIZED IN INTERNAL MEDICINE: WHAT ABOUT THEIR ANEMIA? Anemia in the elderly
1575PDF: 505HTML: 234 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5162PDF: 1323HTML: 2747Cover letter: 194 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3305PDF: 1344HTML: 2655 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3274PDF: 1243HTML: 8106 -
Parasitic hypereosinophilia in childhood: a diagnostic challenge
2563PDF: 810HTML: 292Figure 1: 165 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1548PDF: 882HTML: 981figures: 178table 1: 182table2: 182table3: 183 -
Acquired Hemophilia A successfully treated with rituximab
1938PDF: 1143HTML: 1458Figure 1: 177 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1964PDF: 713HTML: 684Table1: patient's characteristics: 156Table 2: profile of each patient: 178 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1298PDF: 1013HTML: 122 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1285PDF: 724HTML: 322 -
T-LYMPHOCYTES EXPRESSION OF TOLL-LIKE RECEPTORS 2 AND 4 IN ACUTE MYELOID LEUKEMIA PATIENTS WITH INVASIVE FUNGAL INFECTIONS Toll-like receptors 2 and 4 in Acute Myeloid Leukemia Patients with Invasive Fungal Infections
1779PDF: 703HTML: 362 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3554PDF: 2417HTML: 1467







